--- title: "Fresenius Medical Care AG : Release of a capital market information" type: "News" locale: "en" url: "https://longbridge.com/en/news/293197669.md" description: "Fresenius Medical Care AG disclosed an interim report on its share buyback program. Between July 13 and July 17, 2026, the company repurchased a total of 3,294,040 shares through the XETR trading venue. The weighted average purchase price ranged from approximately EUR 41.55 to EUR 42.53 per share. This activity is part of the first tranche of the buyback announced in May 2026." datetime: "2026-07-20T10:14:44.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293197669.md) - [en](https://longbridge.com/en/news/293197669.md) - [zh-HK](https://longbridge.com/zh-HK/news/293197669.md) --- # Fresenius Medical Care AG : Release of a capital market information Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Fresenius Medical Care AG : Release of a capital market information 20.07.2026 / 12:14 CET/CEST Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Fresenius Medical Care AG: Share buyback **Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014** Share buyback – Interim Report In the period from July 13, 2026 to July 17, 2026 (each inclusive), 336,000 shares were bought back within the framework of the first tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on May 28, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows: **Date** **Acquired shares (number)** **Weighted average price (in EUR)** **Transaction volume** **(in EUR)** **Trading venue** 13 July 2026 31,000 42.3704 1,313,482.40 XETR 14 July 2026 1,000 42.5343 42,534.30 XETR 15 July 2026 140,000 41.5538 5,817,532.00 XETR 16 July 2026 84,000 41.9386 3,522,842.40 XETR 17 July 2026 80,000 42.2066 3,376,528.00 XETR A total of 3,294,040 shares has been acquired within the framework of the first tranche of the share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/. 20.07.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Language: English Company: Fresenius Medical Care AG Else-Kröner-Straße 1 61352 Bad Homburg Germany Internet: www.freseniusmedicalcare.com LEI Code: 549300CP8NY40UP89Q40   End of News EQS News Service 2368546 20.07.2026 CET/CEST **Disclaimer** Saving the news in databases or any forwarding of the news to third parties in a commercial context or for commercial purposes is only permitted with the prior written consent of EQS Group AG. ### Related Stocks - [FME.DE](https://longbridge.com/en/quote/FME.DE.md) - [FMS.US](https://longbridge.com/en/quote/FMS.US.md) - [EQS.DE](https://longbridge.com/en/quote/EQS.DE.md) ## Related News & Research - [Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Short Interest Up 87.1% in May](https://longbridge.com/en/news/289735153.md) - [07:01 ETSamaCare Releases Q2 2026 Market Access Benchmarks for Medical Benefit Drugs](https://longbridge.com/en/news/294054234.md) - [Baxter Q2 2026 Earnings Preview](https://longbridge.com/en/news/294224876.md) - [09:10 ETRemarkably Resilient Launches Nationwide Continuing Education to Help Nurses Strengthen Their Own Well-Being](https://longbridge.com/en/news/294213652.md) - [13:55 ETACLM achieves joint accreditation status to independently accredit interprofessional continuing education](https://longbridge.com/en/news/293962404.md)